A gaggle of GOP lawmakers in the U.S. House of Representatives has put ahead the primary marijuana bill for the newly shaped 118th Congress, searching for to amend federal legislation associated to firearm gross sales to medical cannabis customers.
The bill sponsored by Rep. Alex Mooney (R-WV) proposes reforms on the “sale, purchase, shipment, receipt, or possession of a firearm or ammunition by a user of medical marijuana, and for other purposes.”
The present legislation bars the customers of cannabis – both leisure or medical – from buying or possessing weapons because the compound is taken into account a federally managed substance.
The proposed laws introduced in the House on Friday is being cosponsored by Rep. Thomas Massie (R-KY) and Rep. Brian Mast (R-FL), who serves as a co-chair of the Congressional Cannabis Caucus.
While additional particulars of the measure should not but out there, cannabis publication Marijuana Moment mentioned it seems to resemble a earlier bill introduced in 2019, which didn’t clear the legislature.
U.S. MSOs: MedMen Enterprises (OTCQB:MMNFF), Curaleaf Holdings (OTCPK:CURLF), Acreage Holdings (OTCQX:ACRHF), Cresco Labs (OTCQX:CRLBF), Green Thumb Industries (OTCQX:GTBIF), Trulieve Cannabis (OTCQX:TCNNF), Ayr Wellness (OTCQX:AYRWF), Columbia Care (OTCQX:CCHWF), TerrAscend (OTCQX:TRSSF), Clever Leaves Holdings (CLVR)
Canadian Licensed Producers: Canopy Growth (NASDAQ:CGC), Tilray (NASDAQ:TLRY), Cronos (NASDAQ:CRON), Aurora Cannabis (NASDAQ:ACB), Sundial Growers (SNDL), OrganiGram Holdings (OGI), HEXO Corp (HEXO)
Cannabis-focused ETFs: AdvisorShares Pure Cannabis ETF (YOLO), Global X Cannabis ETF (POTX), ETFMG Alternative Harvest ETF(MJ). Amplify Seymour Cannabis ETF (CNBS)
Listed cannabis gamers in the U.S. and Canada have traditionally rallied in response to authorized reforms. In early December, President Joe Biden signed a marijuana analysis bill into legislation reigniting investor curiosity in the trade.